Does Metformin Increase Paraoxonase Activity in Patients with the Metabolic Syndrome? Additional Data from the MEFISTO Study

In a subanalysis on the metformin, arterial function, intima‐media thickness, and nitroxidation in the metabolic syndrome (MEFISTO)(8) (an open‐label fashion, with 1 year of 850 mg daily of metformin) subjects’ samples, we measured the paraoxonase 1 (PON1) activity in 39 patients that finished the s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Sci
Main Authors: Meaney, Eduardo, Sierra‐Vargas, Patricia, Meaney, Alejandra, Guzmán‐Grenfell, Martín, Ramírez‐Sánchez, Israel, Hicks, Juan Jose, Olivares‐Corichi, Ivonne, Ceballos, Guillermo
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Inc 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5439879/
https://ncbi.nlm.nih.gov/pubmed/22686204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1752-8062.2012.00391.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC5439879/
https://ncbi.nlm.nih.gov/pubmed/22686204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1752-8062.2012.00391.x